Literature DB >> 1350982

Changes in expression of CD45R during the development of Th1 and Th2 cell lines.

W T Lee1, E S Vitetta.   

Abstract

Previous studies using anti-CD45R monoclonal antibodies (mAb) have shown that normal CD4+ T cells can be separated into virgin and memory cells based on their level of expression of CD45R. CD45Rhi (virgin) T cells secrete interleukin (IL)-2 whereas CD45Rlo (memory) T cells secrete both IL-2 and IL-4. In contrast to these results, studies using cultured T cell lines have shown that IL-2-secreting T helper cell type 1 (Th1) cells are CD45Rlo and IL-4-secreting Th2 cells are CD45Rhi. To resolve this discrepancy, and to determine how the Th1 and Th2 cell lines relate to memory CD45Rlo and virgin CD45Rhi CD4+ T cells, we have isolated CD45Rlo cells from alloantigen-primed mice and developed allospecific Th1 and Th2 cell lines. The lymphokines secreted by these lines were then evaluated. Our results show that as CD45Rlo T cells develop into in vitro cell lines which secrete IL-4, they become CD45Rhi. In contrast, CD45Rlo cells that develop into lines which secrete IL-2 maintain their CD45Rlo phenotype. Thus, although both Th1 and Th2 cells arise initially from CD45Rlo cells, Th2 cells become CD45Rhi during prolonged in vitro culture but, Th1 cells do not.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350982     DOI: 10.1002/eji.1830220618

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection.

Authors:  S Ibrahim; D V Dawson; P Van Trigt; F Sanfilippo
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

2.  Expression of cytokine mRNA in human melanoma tissues.

Authors:  E C Lattime; M J Mastrangelo; O Bagasra; W Li; D Berd
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

Review 3.  Memory CD4+ T Cells in Immunity and Autoimmune Diseases.

Authors:  Itay Raphael; Rachel R Joern; Thomas G Forsthuber
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.